The largest database of trusted experimental protocols

9 protocols using pac sgrna cas9

1

Generating dTat Knockout Cell Line

Check if the same lab product or an alternative is used in the 5 most similar protocols
The dTat knock-out cell line was made using protocols created by Bassett et al., 2014 (link). A pair of 20-mer oligonucleotides targeting the 5’ end of the dtat coding sequence was ligated into pAc-sgRNA-Cas9 (Addgene) and validated by sequencing. The construct was transfected into low pass S2 cells using TransIT Insect transfection reagent (Mirus) and stable cells carrying indels for this locus were selected for with 5 μg/ml puromycin for 3 weeks. Loss of dTAT was validated by immunoblotting and immunofluorescence for acetylated α-tubulin (Appendix Figure S2A, B). The dTAT knock-out cell line will be distributed through the Drosophila Genomics Resource Center (Bloomington, IN).
+ Open protocol
+ Expand
2

CRISPR-Cas9 Knockout Efficiency Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
S2 cells cultured in 10cm-plates were transfected with 12μg pAC-sgRNA-Cas9 (empty vector, a gift from Dr. Ji-Long Liu, Addgene#49330)(Bassett et al., 2014 (link)), pAC-y1_sgRNA-Cas9 (a gift from Dr. Ji-Long Liu, Addgene#49331)(Bassett et al., 2014 (link)), pAC-PI31_1_sgRNA-Cas9, or pAC-PI31_2_sgRNA-Cas9 with TransIT-Insect transfection reagent (Mirus, #MIR6100). After three days the cells were treated with 5μg/ml puromycin for seven days. Knockout efficiency was examined by western blot analysis.
+ Open protocol
+ Expand
3

Generating Drosophila S2 Knockout Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Drosophila S2 cells were grown at 26°C in Schneider's Drosophila Medium (Life Technologies) supplemented with 10% heat-inactivated FBS (Life Technologies). Cells were passaged 1:5 every 3–5 d. For transfections, cells were plated at a density of 2 million cells/mL, and then transfected with Effectene (Qiagen) according to the manufacturer's protocol. All cell counting was done using a Countess automated cell counter (Invitrogen). To generate knockout lines, cells were transfected with either one (for single-gene knockout) or two (for double knockout) cloned versions of pAc-sgRNA-Cas9 (Addgene #49330), constructed as per previously published protocols (Bassett et al. 2014 (link)) using oligonucleotides listed in Supplemental Table S5. Starting 3 d after transfection, cells were selected with 5 µg/mL puromycin (Life Technologies). After 1 wk of selection, single cells were sorted into wells to generate clonal lines. After culture for 2–3 wk, clonal lines were screened for lesions by PCR amplification of the targeted locus followed by TIDE analysis of the amplicon (Brinkman et al. 2014 (link)).
+ Open protocol
+ Expand
4

Efficient Transfection and Genome Editing of S2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For transfection of S2 cells, effectene (Qiagen) was used according to the manufacturer’s protocol, starting with cells that had been seeded 24 h earlier at a density of 2 million cells/mL (counted with a Countess cell automated counter, Invitrogen). For genome editing, cells were transfected with either one or two clones of pAc-sgRNA-Cas9 (Addgene #49330), constructed with oligonucleotides listed in Table S4 and designed as described (Bassett et al., 2014 (link)). Beginning 3 d post-transfection, cells were selected in puromycin (5 ug/mL, Life Technologies) for one week, and then sorted to establish clonal lines. After growth for 2–3 weeks in conditioned media (filtered media in which S2 cells had been grown for 24 h), genomic DNA was extracted from clonal lines with QuickExtract (Lucigen), and lines were screened for the desired genotype by amplifying the relevant region of the genome (Table S4) and sequencing the amplicon.
+ Open protocol
+ Expand
5

Genetic Manipulation Using CRISPR-Cas9

Check if the same lab product or an alternative is used in the 5 most similar protocols
Actinomycin D and DNA oligonucleotides were purchased from Sigma-Aldrich. Puromycin, hygromycin were purchased from InvivoGen. pAC-sgRNA-cas9 and pAC-y1sgRNA-cas9 plasmids were obtained from Addgene (# 49330 and 49331). Anti-LDH (H-160) antibody was purchased from Santa Cruz (sc-33781). Anti-actin (A2066) antibody was purchased from Sigma-Aldrich. dTIS11 monoclonal antibody was produced as previously described46 (link).
+ Open protocol
+ Expand
6

CRISPR-Mediated dTAT Knockout Cell Line

Check if the same lab product or an alternative is used in the 5 most similar protocols
The dTat knock‐out cell line was made from S2‐DRSC (DGRC Stock 181; https://dgrc.bio.indiana.edu//stock/181; RRID:CVCL_Z992) using protocols created by Bassett et al (2014 (link)). A pair of 20‐mer oligonucleotides targeting the 5′ end of the dtat coding sequence (GTTCGCGCAGCCAATCATCA) was ligated into pAc‐sgRNA‐Cas9 (Addgene) and validated by sequencing. The construct was transfected into low‐pass S2 cells using TransIT Insect transfection reagent (Mirus) and stable cells carrying indels for this locus were selected with 5 μg/ml puromycin for 3 weeks. Loss of dTAT was validated by immunoblotting and immunofluorescence for acetylated α‐tubulin (Appendix Fig S2A and B). The dTAT knock‐out cell line will be distributed through the Drosophila Genomics Resource Center (Bloomington, IN, code DGRC#344).
+ Open protocol
+ Expand
7

CRISPR Library Preparation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 20 nt guide RNA target sites were appended with common adaptor sequences and had the first nucleotide substituted for a G, to improve transcription from the U6:2 promoter. The final sequence was of the format shown in Fig. 2C. Oligonucleotide synthesis for the 68,340 sgRNA sequences was performed by CustomArray Inc, USA, and the assembled oligonucleotide pool was amplified using Phusion polymerase (NEB, UK) and oligonucleotides LibAmpF and LibAmpR (Table S1) with the following thermal cycling parameters (98°C 30 s, 30 cycles of (98°C 15 s, 55°C, 30 s, 72°C 30 s), 72°C 5 min). PCR products were purified using a PCR purification kit (Qiagen, UK), digested with BspQ I (NEB), and 20 nt fragments were extracted from a 20% acrylamide-TBE gel (Life Technologies, UK). Gel extraction was performed by homogenising gel pieces and overnight incubated in 600 μL 0.3 mol/L NaCl. DNA was purified by ethanol precipitation and cloned into pAc-sgRNA-Cas9 (Addgene, #49330, USA) also cut with BspQ I. Approximately 7 × 106 transformants were obtained, corresponding to at least 100-fold coverage of the initial library. Colonies were scraped from bacterial plates and DNA was extracted using a maxiprep kit (Qiagen).
+ Open protocol
+ Expand
8

Generating Dora Gene Constructs for S2 Cell Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
The wild-type Dora CDS was assembled using overlap-extension PCR from portions of the gene that had been amplified from cDNA generated from S2 cells, and cloned into a modified version of pAc-sgRNA-Cas9 (Addgene #49330) that had been double-digested with BstZ17I and SapI to disrupt sgRNA expression. The dora[B] mutant construct was generated from the wild-type construct using Quikchange Site-Directed Mutagenesis (Agilent). The dora[A] mutant construct was generated by PCR amplifying amino acids 1–945 of the Dora CDS, and cloning this amplicon into the double-digested pAc-sgRNA-Cas9. These constructs were transfected into both wild-type and dora S2 cells, and the transfected cells were selected with puromycin (5 ug/mL) for at least 1 week starting three days following transfection. Following puromycin selection, cells were collected, and RNA was extracted.
+ Open protocol
+ Expand
9

CRISPR-Mediated AID Tagging in S2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
SpCas9 and and sgRNAs were expressed in S2 cells from the plasmid pAc-sgRNA-Cas9 (Addgene plasmid #49330). sgRNA sequences used for targeted integration can be found in Table S1. Donors for AID tagging were cloned into pCRIS-PITChv2-FBL (Addgene Plasmid #63672) with 20bp microhomology arms as described in (Sakuma et al., 2016 (link)). For 5’ tagging we generated cassette containing the following construct (5’ BlastRes-P2A-FLAG-AID-3xGGGS 3’) and for 3’ tagging the following (5’ 3xGGGS – AID – FLAG – P2A – BlastREs 3’). AID sequence was ordered as a GeneBlock from IDT, using the mini-degron AID* sequence (IAA17_71-114) from (Morawska and Ulrich, 2013 (link)). Vector maps and plasmids are available upon request.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!